20 million
people globally suffer from pharmaco-resistant epilepsy (~100k in Canada)
20 million
people globally suffer from pharmaco-resistant epilepsy (~100k in Canada)
20 years
lost by patients cycling through medications before surgical referral
Only 1%
of eligible patients undergo surgery each year due to diagnostic uncertainty
The barrier between invisible and undetectable isn't medical, it's technological. We built the technology to eliminate that barrier
Years of epilepsy imaging research have defined the patterns of focal cortical dysplasia and subtle structural abnormalities that standard protocols miss. Over 4,000 epilepsy cases with confirmed surgical outcomes comprise the largest annotated training dataset in the field.
Multiple MRI sequences (T1, FLAIR, diffusion, and functional imaging) processed together capture the specific signatures of epileptic tissue. These sequences reveal tissue patterns that remain invisible to single-modality analysis.
AI analysis identifies lesions expert radiologists cannot see, highlighting surgical targets with precision. International epilepsy specialists review every diagnostic output to ensure clinical accuracy. AI assists clinical judgment but never replaces it.
Published, peer-reviewed algorithms rather than proprietary black boxes ensure transparency. Core components remain open to scientific scrutiny. Six software toolboxes have achieved 40,000+ downloads and 1,500+ citations across the research community.
BrainScores was built exclusively for epilepsy surgery. Generic neuroimaging platforms serve multiple conditions but lack the depth required for focal cortical dysplasia detection.
STANDARD MRI:
Negative
BRAINSCORES ANALYSIS:
Lesion detected in right frontal cortex
SURGICAL OUTCOME:
Seizure-free at 12 months

MRI-NEGATIVE

AUTOMATED DEVIATION MAPPING

AI DIAGNOSTICS

CURATIVE SURGERY
STANDARD MRI:
Negative
BRAINSCORES ANALYSIS:
Hippocampal abnormality identified
SURGICAL OUTCOME:
Seizure-free at 18 months

MRI-NEGATIVE

AUTOMATED DEVIATION MAPPING

AI DIAGNOSTICS

CURATIVE SURGERY
From raw MRI data to surgical navigation in a single integrated system
Step 01
Multi-modal MRI standardization and quality control form the open-source foundation available for research use
Step 02
Whole-brain morphometric mapping reveals deviation patterns across cortical and subcortical structures
Step 03
AI-powered lesion identification combined with expert radiologist validation delivers comprehensive case reports
Step 04
Direct data export to neuronavigation systems from Medtronic, ROSA, Brainlab, and Zimmer Biomet

Jordan De Kraker, PhD
Co-founder, CEO
Postdoctoral Researcher, Montreal Neurological Institute

Boris Bernhardt, PhD
Co-founder, CSO
Associate Professor of Neurology and Neurosurgery, Canada Research Chair, Montreal Neurological Institute

Philippe Benjamin-Duranceau
Co-founder, COO

Ian Goodall-Halliwell
Software developer
PhD student, Montreal Neurological Institute

Enning Yang
Research Software developer
Montreal Neurological Institute

Raul Cruces, MD PhD
Consultant
Research Associate, Montreal Neurological Institute

Judy Chen
Data Analyst
MD-PhD student, Montreal Neurological Institute

Ali Khan, PhD
AI advisor
Associate Professor in Medical Biophysics, Western University

Alan Evans, PhD
Scientific Advisor
Distinguished James McGill Professor of Neurology and Neurosurgery and Psychiatry, Montreal Neurological Institute

Neda Ladbon-Bernasconi, MD PhD
Clinical Advisor
Neuroimaging of Epilepsy, Montreal Neurological Institute

Alexander Weil, MD
Clinical Advisor
CHU Sainte-Justine

Andrea Bernasconi, MD
Clinical Advisor
Neurologist epileptologist, Montreal Neurological Institute
Research
leadership
Decades of leading international task forces and ILAE consortia in epilepsy imaging.
40k+
downloads
Six published software toolboxes with 1,500+ citations across the research community.








10+ collaborating centers
Schedule a call to discuss your institution's needs and review case demonstrations relevant to your patient population.
partners@brainscores.aiWe partner with epilepsy centers on validation studies and novel diagnostic approaches. Active projects underway in Montreal, Toronto, New York, and Boston.
research@brainscores.aiWe're building technology that changes lives. If that matters to you, we should talk.
career@brainscores.ai